The efflux of anthracyclines in multidrug-resistant cell lines
- 1 October 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (8) , 1317-1326
- https://doi.org/10.1016/0006-2952(93)90094-d
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factorsCancer Treatment Reviews, 1990
- 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistanceEuropean Journal of Cancer and Clinical Oncology, 1990
- Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicinEuropean Journal of Haematology, 1987
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1978
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- Electronic Absorption Spectra and Protolytic Equilibria of Doxorubicin: Direct Spectrophotometric Determination of MicroconstantsJournal of Pharmaceutical Sciences, 1977
- Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1977
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- A fluorometric assay for daunomycin and adriamycin in animal tissuesBiochemical Medicine, 1973